TELA Bio, Inc. is a commercial stage medical technology company, which focuses on the design, development, and market of tissue reinforcement materials. The company was founded by Antony Koblish and Maarten Persenaire on April 17, 2012 and is headquartered in Malvern, PA.
Fundamentals
Mkt Cap
$31.11M
Volume
-
52W High
$1.50
52W Low
$0.5011
PE Ratio
-0.92
Avg. Volume
142,349.50
EPS (Annual)
-$0.8271
P/B
-1.26
Rev/Employee
$368,233.95
Earnings
Nov 10
48
Neutral Sentiment
How do you feel about TELA?
Dr_Monkeybreath
$TELA kinda surprised it went up after earnings. ready to rebuild my position at or below .70. ⏳🍽️
1
StocktwitsEarnings
$TELA Q3 '26 Earnings Results & Recap
• Reported GAAP EPS of -$0.13 up 27.78% YoY
• Reported revenue of $18.96M down -8.36% YoY
• TELA Bio announced and implemented a strategic cost reduction initiative to reduce annual operating expenses by $17M and extend cash runway into 2028; no revenue or earnings range was provided.
Link your Stocktwits account
Ask your agent for live sentiment, watchers, trending tickers, and news.